Dr. Jeannie T. Lee is the Phillip A. Sharp Chair of the Department of Molecular Biology at Massachusetts General Brigham (MGB) and also holds the title of Vice Chair of the Department and Professor of Genetics at Harvard Medical School (HMS). She specializes in the study of epigenetic regulation by long noncoding RNAs and uses X-chromosome inactivation as a model system. She is a member of the National Academy of Sciences, the National Academy of Medicine, and Academia Sinica. She is also a Harrington Rare Disease Scholar of the Harrington Discovery Institute, a recipient of the Lurie Prize from the Foundation for the National Institutes of Health, an awardee of the Centennial Prize from the Genetics Society of America, the 2010 Molecular Biology Prize and the 2020 Cozzarelli Prize from the National Academy of Sciences, U.S.A, and a Fellow of the American Association for the Advancement of Science. Dr. Lee was also named a Distinguished Graduate of the University of Pennsylvania School of Medicine and an Investigator of the Howard Hughes Medical Institute. From 2013-18, she co-launched the Epigenetics Initiative at Harvard Medical School and served as its Co-Director. Serving on the Board of Directors of the Genetics Society of America (GSA), she spearheaded the TAGC (The All-Genetics) Conference in 2016. As GSA’s President, Dr. Lee established a Strategic Plan and a Development strategy for the society in 2018. Dr. Lee received her A.B. in Biochemistry and Molecular Biology from Harvard University and obtained MD and PhD degrees from the University of Pennsylvania School of Medicine. She carried out postdoctoral work at the Whitehead Institute & MIT and was Chief Resident of Clinical Pathology at MGB prior to joining the molecular biology faculty.